PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel anti-malarial drug target identified

2012-07-20
(Press-News.org) An international team of scientists, led by researchers from the Department of Pediatrics at the University of California, San Diego School of Medicine, have identified the first reported inhibitors of a key enzyme involved in survival of the parasite responsible for malaria. Their findings, which may provide the basis for anti-malarial drug development, are currently published in the online version of the Journal of Medicinal Chemistry.

Tropical malaria is responsible for more than 1.2 million deaths annually. Severe forms of the disease are mainly caused by the parasite Plasmodium falciparum, transmitted to humans by female Anopheles mosquitoes. Malaria eradication has not been possible due to the lack of vaccines and the parasite's ability to develop resistance to most drugs.

The researchers conducted high-throughput screening of nearly 350,000 compounds in the National Institutes of Health's Molecular Libraries Small Molecule Repository (MLSMR) to identify compounds that inhibit an enzyme which plays an important role in parasite development: Plasmodium falciparum glucose-6-phosphate dehydrogenase (PfG6PD) is essential for proliferating and propagating P. falciparum.

"The enzyme G6PD catalyzes an initial step in a process that protects the malaria parasite from oxidative stress in red blood cells, creating an environment in which the parasite survives," said senior author Lars Bode, PhD, assistant professor in the UCSD Department of Pediatrics, Division of Neonatology and the Division of Gastroenterology, Hepatology and Nutrition. People with a natural deficiency in this enzyme are protected from malaria and its deadly symptoms, an observation that triggered the reported research.

The parasitic form of the enzyme (PfG6PD) is what contributes the majority of G6PD activity in infected red blood cells. Because the parasite lives in the blood of a malaria-infected person, the scientists aimed at identifying compounds that inhibit the parasitic form but not the human form of the enzyme. "We didn't want to interfere with the human form of the enzyme and risk potential side effects," Bode explained.

Scientific testing had previously been limited by a lack of recombinant PfG6PD. Team members in the lab of Katja Becker, PhD, at the Interdisciplinary Research Center at Justus-Liebig-University in Giessen, Germany produced the first complete and functional recombinant PfG6PD, and researchers led by Anthony Pinkerton, PhD, at Sanford-Burnham Medical Research Institute used it to identify the lead compound resulting from their efforts, ML276.

ML276 represents the first reported selective PfG6PD inhibitor, which stops the growth of malaria parasites in cultured red blood cells – even those parasites that developed resistance to currently available drugs. "ML276 is a very promising basis for future drug design of new anti-malarial therapeutics," said Bode.



INFORMATION:



Contributors to the study include Janina Preuss, UC San Diego, Justus-Liebig-University and Sanford-Burnham Medical Research Institute; Esther Jortzik, Stefan Rahlfs and Katja Becker, Justus-Liebig-University; Patrick Maloney, Satyamaheshwar Peddibhotla, Paul Hershberger, Eliot Sugarman, Becky Hood, Eigo Suyama, Kevin Nguyen, Stefan Vasile, Arianna Mangravita-Novo, Michael Vicchiarelli, Danielle McAnally, Layton H. Smith. Gregory P. Roth, Michael P. Hedrick, Palak Gosalia, Monika Milewski, Yujie Linda Li, Eduard Sergienko, Jena Diwan, Thomas D.Y. Chung, and Anthony B. Pinkerton, Sanford-Burnham.

The study was supported by the National Institutes of Health (1R21AI082434), the Deutsche Forschungsgemeinschaft, and an NIH Molecular Libraries grant (U54 HG005033) to the Conrad Prebys Center for Chemical Genomics at Sanford Burnham Medical Research Institute, one of the comprehensive centers of the NIH Molecular Libraries Probe Production Centers Network (MLPCN).



ELSE PRESS RELEASES FROM THIS DATE:

Blood vessel forming potential of stem cells from human placenta and umbilical cord blood

2012-07-20
Tampa, Fla. (July 19, 2012) – A study comparing whether endothelial colony-forming cells (ECFCs) derived from human placenta or those derived from human umbilical cord blood are more proliferative and better for forming new blood vessels has found that ECFCs derived from human placenta are more vasculogenic. The study, carried out by researchers at the Indiana School of Medicine, is published in a recent issue of Cell Medicine [2(3)] and is freely available on-line at: http://www.ingentaconnect.com/content/cog/cm. "Circulating ECFCs isolated from umbilical cord blood ...

Being in awe can expand time and enhance well-being

2012-07-20
It doesn't matter what we've experienced – whether it's the breathtaking scope of the Grand Canyon, the ethereal beauty of the Aurora Borealis, or the exhilarating view from the top of the Eiffel Tower – at some point in our lives we've all had the feeling of being in a complete and overwhelming sense of awe. Awe seems to be a universal emotion, but it has been largely neglected by scientists—until now. Psychological scientists Melanie Rudd and Jennifer Aaker of Stanford University Graduate School of Business and Kathleen Vohs of the University of Minnesota Carlson ...

Colorful science sheds light on solar heating

2012-07-20
A crucial, and often underappreciated, facet of science lies in deciding how to turn the raw numbers of data into useful, understandable information – often through graphs and images. Such visualization techniques are needed for everything from making a map of planetary orbits based on nightly measurements of where they are in the sky to colorizing normally invisible light such as X-rays to produce "images" of the sun. More information, of course, requires more complex visualizations and occasionally such images are not just informative, but beautiful too. Such is the ...

IRVE-3 flight hardware test sounding rocket

2012-07-20
NASA will launch an inflatable aeroshell/heat shield technology demonstrator on a Black Brant XI sounding rocket July 22 from the agency's launch range at the Wallops Flight Facility in Virginia. The Inflatable Reentry Vehicle Experiment (IRVE-3) is the third in a series of suborbital flight tests of this new technology. Technicians will vacuum pack the uninflated 10-foot (3.05 meters) diameter cone of high-tech inner tubes into a 22-inch (56 centimeters) diameter sounding rocket. During the flight test an on board system will inflate the tubes -- stretching a thermal ...

Tropical Depression Khanun blankets South Korea

2012-07-20
Tropical Depression Khanun came ashore with some heavy rainfall in the morning hours (local time) on Thursday, July 19. NASA's Terra satellite captured an image of Khanun's clouds on July 19, covering all of South Korea like a blanket. The Moderate Resolution Imaging Spectroradiometer (MODIS) instrument onboard NASA's Terra satellite captured a true-color image of Tropical Depression Khanun over South Korea on July 19, 2012 at 0225 UTC, or 11:25 a.m. local time, Seoul (10:25 p.m. EDT/U.S. on July 18). The last advisory on Khanun from the Joint Typhoon Warning Center ...

Vitamin D may protect against lung function impairment and decline in smokers

2012-07-20
Vitamin D deficiency is associated with worse lung function and more rapid decline in lung function over time in smokers, suggesting that vitamin D may have a protective effect against the effects of smoking on lung function, according to a new study from researchers in Boston. "We examined the relationship between vitamin D deficiency, smoking, lung function, and the rate of lung function decline over a 20 year period in a cohort of 626 adult white men from the Normative Aging Study," said lead author Nancy E. Lange, MD, MPH, of the Channing Laboratory, Brigham and ...

CPAP treatment effective in patients with milder OSA and daytime sleepiness

2012-07-20
Continuous positive airway pressure (CPAP), well established as an effective treatment for severe obstructive sleep apnea (OSA), is also effective in patients with mild and moderately severe OSA and daytime sleepiness, according to a new study. "The evidence for the efficacy of CPAP in patients with milder OSA is limited and conflicting," said lead author Terri E. Weaver, PhD, RN, professor and dean of the University of Illinois at Chicago College of Nursing. "Our multi-site, double-blind, randomized trial, the first placebo-controlled study to use sham CPAP in sleepy ...

Rutgers study: Anxiety disorders in poor moms likely to result from poverty, not mental illness

2012-07-20
NEW BRUNSWICK, N.J. – Poor mothers are more likely to be classified as having the mental illness known as generalized anxiety disorder (GAD) because they live in poverty – not because they are suffering from a psychiatric disorder, according to Rutgers researchers. Judith C. Baer, an associate professor in the School of Social Work, and her team, in the study, "Is it Generalized Anxiety Disorder or Poverty? An Examination of Poor Mothers and Their Children," published online in Child and Adolescent Social Work, argue that although high levels of stress over long periods ...

Racially diverse suburbs growing faster than white suburbs but resegregation threatens prosperity

2012-07-20
Racially diverse suburbs are growing faster than white suburbs, but resegregation threatens their prosperity and stability, according to a study entitled, "America's Racially Diverse Suburbs: Opportunities and Challenges," released this week by the Institute on Metropolitan Opportunity at the University of Minnesota Law School. Long perceived as predominantly prosperous white enclaves, suburbs are now at the cutting edge of racial, ethnic and political change in America. The study finds the number of racially diverse suburbs, municipalities ranging from 20-60 percent ...

AbetterlifeThailand.com Helps People on a Budget Live an Affluent Lifestyle in Thailand

2012-07-20
As more people struggle to afford food, housing, transportation and medical care, one company has introduced a unique solution for the rising cost of living in America. The founders of A Better Life announced today the release of its initial website, http://www.abetterlifeThailand.com, aimed at people wanting to live a better life, by helping them relocate to exotic Thailand. Entrepreneurs David Yow and Gary Orman saw a need in the marketplace for a turnkey solution where they help people to visit or relocate to Thailand because of its luxurious yet affordable lifestyle, ...

LAST 30 PRESS RELEASES:

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

A surgical handover system for patient physiology and safety

Cardiovascular health changes in young adults and risk of later-life cardiovascular disease

Nurse workload and missed nursing care in neonatal intensive care units

How to solve the remote work stalemate – dissertation offers tools for successful hybrid work

Chip-based phonon splitter brings hybrid quantum networks closer to reality

Texas Children’s researchers create groundbreaking tool to improve accuracy of genetic testing

Milken Institute, Ann Theodore Foundation announce more than $2.5 million in new funding for sarcoidosis research and launch new call for proposals

Boston University professor to receive 2025 Eugene Braunwald Academic Mentorship Award

Pusan National University researchers reveal how forest soil properties influence arsenic mobility and toxicity in soil organisms

Korea University researchers find sweet taste cells resist nerve damage through c-Kit protein

HealthFORCE, AAPA, and West Health release “Aging Well with AI” – first in a two part series on AI and the healthcare workforce

The real reasons Endurance sank — study finds Shackleton knew of ship’s shortcomings

Marine heatwaves have hidden impacts on ocean food webs and carbon cycling

[Press-News.org] Novel anti-malarial drug target identified